Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets...
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.91 |
Change
-0.030(0.15%) |
Mkt cap ! $2.544B |
Open | High | Low | Value | Volume |
$19.95 | $20.00 | $19.50 | $8.294M | 417.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 443 | $19.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.91 | 917 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3395 | 19.750 |
3 | 6690 | 19.720 |
1 | 1119 | 19.710 |
1 | 1192 | 19.700 |
1 | 1119 | 19.670 |
Price($) | Vol. | No. |
---|---|---|
19.940 | 1119 | 1 |
19.960 | 528 | 1 |
19.980 | 1119 | 1 |
20.000 | 52 | 1 |
20.030 | 1119 | 1 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online